Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Walgreens Boots Alliance (NASDAQ: WBA ) stock is taking a beating on Tuesday after the company warned investors of lower earnings in its latest report. According to Walgreens Boots Alliance, several factors are weighing on its business for 2023.

Why Is Walgreens Boots Alliance (WBA) Stock Down 9% Today?

Walgreens Boots Alliance Inc (NASDAQ:WBA) reported fiscal third-quarter earnings that missed Wall Street's expectations, and lowered its full-year earnings guidance.

Blue-Chip Pharma Stock Hits 13-Year Low After Earnings

Shares of Walgreens Boots Alliance Inc. WBA, -10.37% tumbled 10.2% in morning trading Tuesday, enough to pace both the Dow Jones Industrial Average's DJIA, +0.28% and the S&P 500's SPX, +0.29% losers. The stock's selloff comes after the drugstore chain and health care services company's reported fiscal third-quarter profit that missed expectations and slashed its full-year outlook.

Walgreens stock tumbles toward a 12-year low, cuts 22 points off the Dow's price

Walgreens' stock hasn't performed well recently, but that may change soon. Its shares are cheap, and management is predicting good results for Q3 and Q4.

Walgreens Stock Could Rise 23%, According to Wall Street. Is That Realistic?

Apple

AMC Entertainment

Amazon

Blackstone Group

Colgate-Palmolive

GameStop

Halcon Resources

Lucid Group

Manchester United

Mullen Automotive

NVIDIA

Lordstown Motors

Snowflake

Tesla

Walmart

The quarter is winding down and with it, a bit of steam for the stock market as some say investors are finally facing up to fading hopes for Fed rate cuts in 2023. The S&P 500 SPX, +0.32% and Nasdaq Composite COMP, +0.61% have each logged five losing sessions out of the last six.

A summer battle of the stock bulls and bears is brewing. Here's how you play both sides of that.

Markets were mixed early Tuesday morning. Walgreens stock fell after the drugstore chain adjusted its earnings guidance lower.

These 2 Stocks Are Moving Markets Tuesday Morning

The drugstore chain says it will step up cost-cutting measures and boost the long-term profitability of its healthcare business.

Walgreens Lowers Outlook Amid Weaker Retail Consumer Spending

A plunge in demand for Covid-19 related services, and increasingly cautious consumers focused on value were behind the pharmacy chain's disappointing third quarter update.

Walgreens Stock Tumbles. It Slashes Outlook as Shoppers Grow More Cautious.

Walgreens Boots Alliance (NASDAQ: WBA), the second-biggest retail pharmacy company in the US, published mixed results on Tuesday. Its revenue came in at over $35.42 billion, representing a 8.7% year-on-year growth.

Walgreens Boots Alliance slashes guidance as profits retreat

Shares of Walgreens Boots Alliance Inc. WBA, +0.61% sank 6.1% toward an 11-year low in premarket trading Tuesday, after the drug store chain and health care services company reported fiscal third-quarter profit that missed expectations and slashed its full-year outlook, citing “challenging consumer and macroeconomic conditions, and lower COVID-19 vaccine and testing volumes.” Net income for the quarter to May 31 fell to $118 million, or 14 cents a share, from $289 million, or 33 cents a share, in the year-ago period.

Walgreens stock drops toward 11-year low after profit miss, slashed full-year outlook

Walgreens Boots Alliance profits fell to $118 million – less than half of what they were a year ago – due to “significantly lower demand for COVID-related services.”

Walgreens Profits Tumble To $118 Million On ‘Significantly Lower Demand' For Covid Vaccine And Tests

CEO Rosalind Brewer said Walgreens will increase its cost-cutting program to $4.1 billion and take action to increase profitability in the health-care segment.

Walgreens slashes earnings guidance due to lower consumer spending, drop in Covid care demand

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance reports fiscal 2023 third quarter results.

Walgreens Boots Alliance Reports Fiscal 2023 Third Quarter Results

NIKE

The Dow has underperformed other market indexes so far in 2023. Walgreens Boots Alliance is trying to bounce back from a stock price decline that has sent shares close to decade lows.

The 2 Dow Jones Stocks Investors Must Watch This Week

Johnson & Johnson

Coca-Cola

Coca-Cola currently offers a 3% dividend yield. Johnson & Johnson pays a very healthy dividend.

Got $500? 3 Magnificent Dividend Stocks to Buy Without Hesitation Right Now

Carnival

Roku

Teladoc

Despite the rebounding market, Carnival Cruise Lines' high debt and ongoing losses undermine its long-term investment value. Walgreens' pivot towards primary care comes with stiff competition from giants like CVS Health, Walmart, and Amazon.

2 Stocks to Avoid Next Week, and 2 to Consider Instead

Earnings season's regular doldrums have settled in, and we can expect to see only a handful of reports out for the next two weeks.

Will Walgreens Earnings Blow Past Estimates Again?

CNBC's Jim Cramer gave investors his game plan for the week ahead, with companies like Nike and Walgreens set to report.

Jim Cramer gives his game plan for the week ahead, with Nike and Walgreens set to report

Amgen

Boeing

Salesforce

Goldman Sachs

Merck

Microsoft

The Dow Jones Industrial Average closed down 0.01%, or 4 points, spending most of the day in the red as investors digested the latest moves by central banks around the world.

Dow Jones Today: Index Flat as Investors Mull Global Rate Decisions

Arbor Realty Trust

SoFi Technologies

The Dividend Harvesting Portfolio is establishing a new uptrend, with a balance of $12,212.58 after 120 weeks and $12,000 allocated. The portfolio generated $13.63 in dividend income in week 120, bringing the 2023 total dividend income to $402.69. The author plans to allocate capital toward BDCs in week 121, eyeing Ares Capital, Owl Rock Corporation, and FS KKR Capital Corp.

Dividend Harvesting Portfolio Week 120: $12,000 Allocated, $1019.48 In Projected Dividends

Walgreens offers a sizable dividend and has raised it for 47 consecutive years. However, the pharmacy chain has been investing billions to expand its healthcare business.

Will Walgreens Increase Its Dividend in July?

DEERFIELD, Ill.--(BUSINESS WIRE)--To express gratitude for an incredibly significant part of American history and to honor those who have served – and continue to serve – our country, Walgreens is offering a weekend Independence Day discount to all veterans, active duty military personnel and their immediate family members, including the families of veterans. Beginning July 1 through July 4, customers with a valid military ID or proof of service will receive 20 percent off regularly priced prod.

Walgreens Honors Veterans, Active Duty Military and Families with Weekend Discount in Honor of Independence Day Saturday, July 1 through Tuesday, July 4

Walgreens Boots Alliance Inc  (NASDAQ:WBA) stock is flat today, last seen trading at $32.67, as the Dow Jones Industrial Average (DJIA) paces for its  worst drop since early May.

Walgreens Stock's Recent Bounce May Be Short-Lived

Investors are optimistic about Walgreens Boots (WBA) on a strong focus on strategic priorities.

Why You Should Retain Walgreens Boots (WBA) Stock for Now

Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

News for Walgreens Stock (WBA)